Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
41.67
+0.68 (1.66%)
At close: Dec 5, 2025, 4:00 PM EST
42.00
+0.33 (0.79%)
After-hours: Dec 5, 2025, 4:43 PM EST
KNSA Market Cap
KNSA has a market cap or net worth of $3.16 billion as of December 5, 2025. Its market cap has increased by 103.46% in one year.
Market Cap
3.16B
Enterprise Value
2.82B
1-Year Change
103.46%
Ranking
Category
Stock Price
$41.67
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $943.14M to $3.16B, an increase of 234.88%. That is a compound annual growth rate of 17.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 3.11B | 117.55% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.45% |
| Dec 30, 2022 | 1.04B | 28.46% |
| Dec 31, 2021 | 810.82M | -32.59% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |